XNCR Q4 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M-86.0% YoY

Gross Profit

-$30M-138.1% margin

Operating Income

-$43M-197.1% margin

Net Income

-$12M-55.7% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-20.8%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$35M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$846M

Total Liabilities

$119M

Stockholders' Equity

$727M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$154M	-86.0%
Gross Profit	-$30M	$103M	-129.0%
Operating Income	-$43M	$92M	-146.5%
Net Income	-$12M	$73M	-116.5%

Revenue Segments

Royalty

$16M75%

Research collaboration

$5M23%

Milestone

$500,0002%